199 related articles for article (PubMed ID: 32718257)
1. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
2. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
3. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.
Pastori D; Pignatelli P; Menichelli D; Violi F; Lip GYH
Mayo Clin Proc; 2019 Jul; 94(7):1261-1267. PubMed ID: 30551910
[TBL] [Abstract][Full Text] [Related]
4. Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.
Chang SH; Kuo CF; Chou IJ; See LC; Yu KH; Luo SF; Huang LH; Zhang W; Doherty M; Wen MS; Kuo CT; Yeh YH
JAMA Cardiol; 2017 Aug; 2(8):863-870. PubMed ID: 28678986
[TBL] [Abstract][Full Text] [Related]
5. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
6. Cancer-specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO-AF study.
Pastori D; Menichelli D; Bucci T; Violi F; Pignatelli P;
Int J Cancer; 2020 Dec; 147(12):3424-3430. PubMed ID: 32588421
[TBL] [Abstract][Full Text] [Related]
7. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
[TBL] [Abstract][Full Text] [Related]
8. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.
Pokorney SD; Piccini JP; Stevens SR; Patel MR; Pieper KS; Halperin JL; Breithardt G; Singer DE; Hankey GJ; Hacke W; Becker RC; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; ;
J Am Heart Assoc; 2016 Mar; 5(3):e002197. PubMed ID: 26955859
[TBL] [Abstract][Full Text] [Related]
9. Risk of Stroke in Patients With Atrial Fibrillation Is Associated With Stroke in Siblings: A Nationwide Study.
Berntsson J; Li X; Zöller B; Martinsson A; Andell P; Lubitz SA; Engström G; Sundquist K; Smith JG
J Am Heart Assoc; 2020 Feb; 9(3):e014132. PubMed ID: 32009521
[TBL] [Abstract][Full Text] [Related]
10. Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation.
Hämmerle P; Eick C; Blum S; Schlageter V; Bauer A; Rizas KD; Eken C; Coslovsky M; Aeschbacher S; Krisai P; Meyre P; Vesin JM; Rodondi N; Moutzouri E; Beer J; Moschovitis G; Kobza R; Di Valentino M; Corino VDA; Laureanti R; Mainardi L; Bonati LH; Sticherling C; Conen D; Osswald S; Kühne M; Zuern CS;
J Am Heart Assoc; 2020 Aug; 9(15):e016075. PubMed ID: 32750290
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
12. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
[TBL] [Abstract][Full Text] [Related]
14. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
[TBL] [Abstract][Full Text] [Related]
16. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Atrial Fibrillation in Lower Limb Amputee Patients.
Ralevic S; Perunicic J; Lasica R; Marinkovic J; Blagojevic T; Simanic I; Asanin M; Stankovic G
Eur J Vasc Endovasc Surg; 2016 Dec; 52(6):823-829. PubMed ID: 27789143
[TBL] [Abstract][Full Text] [Related]
19. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
20. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
